• Català
  • Castellano
  • English
  • Cancer Prevention and Control Program
    • Biomarkers
      • Group
      • Research
      • Projects
      • Publications
      • Applications
      • Contact
    • Tobacco
      • Group
      • Research
      • Projects
      • Publications
      • Applications
      • Contact
    • Screening
      • Group
      • Research
      • Projects
      • Publications
      • Contact
  • Education & Teaching
  • Work with us
  • How to arrive

            hubc.png

Home ›

Publications

  • List
  • Filter
  • Author
  • Keyword
  • Title  (Asc)
  • Type
  • Year
Filters: Author is Abad, A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
Martinez-Balibrea E, Abad A, Aranda E, Sastre J, Manzano JL, Díaz-Rubio E, et al. Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer. European journal of cancer (Oxford, England : 1990). 2008;44(9):1229-37. Abstract
U
Martinez-Balibrea E, Abad A, Martínez-Cardús A, Ginés A, Valladares M, Navarro M, et al. UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy. British journal of cancer. 2010;103(4):581-9. Abstract

© Catalan Institute of Oncology

Syndicate content